<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2151">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04476589</url>
  </required_header>
  <id_info>
    <org_study_id>2020P001616</org_study_id>
    <nct_id>NCT04476589</nct_id>
  </id_info>
  <brief_title>Prognostication of Recovery in Early Disorders of Consciousness After COVID-19</brief_title>
  <acronym>PREDICT-COVID</acronym>
  <official_title>Prognostication of Recovery in Early Disorders of Consciousness After COVID-19</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Massachusetts General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary aim of this research proposal is to use multimodal metrics (e.g., clinical data
      and advanced neuroimaging) in the early (i.e., acute hospitalization) phase of recovery from
      COVID-19-related disorders of consciousness to predict outcome at 3, 6, and 12 months
      post-hospitalization. We aim to construct an algorithm that synthesizes the results of these
      metrics to help predict recovery.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 1, 2020</start_date>
  <completion_date type="Anticipated">March 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Disability Rating Scale score</measure>
    <time_frame>6 months</time_frame>
    <description>functional outcome measure</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Covid19</condition>
  <condition>Coma</condition>
  <condition>Consciousness Disorder</condition>
  <arm_group>
    <arm_group_label>COVID-19 Disorders of Consciousness</arm_group_label>
    <description>Patients with COVID-19 and disorders of consciousness</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Functional MRI</intervention_name>
    <description>measurement of functional brain networks</description>
    <arm_group_label>COVID-19 Disorders of Consciousness</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Survivors of severe COVID-19 who have disorders of consciousness
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. age 18 or older,

          2. positive diagnosis of COVID-19,

          3. diagnosis of coma, vegetative state or minimally conscious state per Glasgow Coma
             Scale (GCS) at time of enrollment (excluding confounders such as sedation) and

          4. clinical team plan for an MRI for clinical management.

        Exclusion Criteria:

        A subject with any of the following MRI contraindications will not be eligible for this
        study:

          -  electrical implants such as cardiac pacemakers or perfusion pumps

          -  ferromagnetic implants such as aneurysm clips, surgical clips, prostheses, artificial
             hearts, valves with steel parts, metal fragments, shrapnel, tattoos near the eye, or
             steel implants

          -  ferromagnetic objects such as jewelry or metal clips in clothing that cannnot be
             easily removed for scanning

          -  pregnant volunteers
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>David Fischer, MD</last_name>
    <phone>617-726-2000</phone>
    <email>dfischer2@mgh.harvard.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Brian L Edlow, MD</last_name>
    <phone>617-724-6352</phone>
    <email>bedlow@mgh.harvard.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brian L. Edlow, M.D.</last_name>
      <email>bedlow@mgh.harvard.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Fischer D, Threlkeld ZD, Bodien YG, Kirsch JE, Huang SY, Schaefer PW, Rapalino O, Hochberg LR, Rosen BR, Edlow BL. Intact Brain Network Function in an Unresponsive Patient with COVID-19. Ann Neurol. 2020 Jul 1. doi: 10.1002/ana.25838. [Epub ahead of print]</citation>
    <PMID>32613682</PMID>
  </results_reference>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>July 16, 2020</study_first_submitted>
  <study_first_submitted_qc>July 16, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 20, 2020</study_first_posted>
  <last_update_submitted>July 16, 2020</last_update_submitted>
  <last_update_submitted_qc>July 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Massachusetts General Hospital</investigator_affiliation>
    <investigator_full_name>Brian L. Edlow, M.D.</investigator_full_name>
    <investigator_title>Neurocritical Care Faculty</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Consciousness Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

